Stockreport

Gilead Has A Lot Of Explaining To Do Thursday [Seeking Alpha]

GlaxoSmithKline PLC  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF SummaryGILD reports earnings Thursday.Growth could be dead for now. HCV revenue is in decline, and Yescarta's revenue is stagnating.A recent patent infringement lawsuit [Read more]